Maravai LifeSciences (NASDAQ:MRVI) Stock Rating Lowered by Robert W. Baird
Robert W. Baird downgraded shares of Maravai LifeSciences (NASDAQ:MRVI – Free Report) from an outperform rating to a neutral rating in a research report released on Wednesday, MarketBeat reports. They currently have $3.00 price target on the stock, down from their previous price target of $9.00. A number of other analysts also recently weighed in […]
Robert W. Baird downgraded shares of Maravai LifeSciences (NASDAQ:MRVI – Free Report) from an outperform rating to a neutral rating in a research report released on Wednesday, MarketBeat reports. They currently have $3.00 price target on the stock, down from their previous price target of $9.00. A number of other analysts also recently weighed in […]
